Enrollment information and FAQs
The IFOPA is pleased to share the announcement and new FAQs from Clementia Pharmaceuticals regarding the palovarotene clinical trial.
To read the announcement click Next Step in Clementia’s Clinical Program for FOP.
To read the new FAQs click Frequently Asked Questions.
Do you like this post?